Treatment for DLBCL typically involves a combination of chemotherapy, immunotherapy, and sometimes radiation therapy. The standard chemotherapy regimen is known as R-CHOP, which includes a combination of drugs and the monoclonal antibody rituximab. In some cases, a stem cell transplant may be considered, especially for relapsed or refractory DLBCL.
